Clincosm LogoSign in Get a demo

Solid Tumor

Showing NaN - NaN of 79
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor Trial in United States (68Ga-FAP-2286, 177Lu-FAP-2286)

Recruiting
  • Solid Tumor
  • Birmingham, Alabama
  • +5 more
Aug 26, 2022

Solid Tumor, Lymphoma Trial in China, United States (TJ011133, Pembrolizumab, Rituximab)

Active, not recruiting
  • Solid Tumor
  • Lymphoma
  • Birmingham, Alabama
  • +20 more
Aug 22, 2022

Solid Tumor Trial in United States (NeoTCR-P1 adoptive cell therapy, nivolumab, IL-2)

Suspended
  • Solid Tumor
  • NeoTCR-P1 adoptive cell therapy
  • +2 more
  • Duarte, California
  • +8 more
Aug 16, 2022

Solid Tumor, Solid Tumor, Adult, Solid Tumor, Unspecified, Adult Trial in Bronx, New York, Ponce (Meaning Centered Psychotherapy

Recruiting
  • Solid Tumor
  • +2 more
  • Meaning Centered Psychotherapy for Latinos
  • +3 more
  • Bronx, New York
  • +3 more
Aug 16, 2022

Endometrial Tumors, Ovarian Cancer, Solid Tumor Trial in United States (COM701 in combination with BMS-986207 and nivolumab.)

Recruiting
  • Endometrial Neoplasms
  • +3 more
  • COM701 in combination with BMS-986207 and nivolumab.
  • Chicago, Illinois
  • +8 more
Aug 8, 2022

Solid Tumor, Advanced Cancer, Metastatic Cancer Trial in China, United States (TJ033721)

Recruiting
  • Solid Tumor
  • +6 more
  • Orange, California
  • +17 more
Aug 9, 2022

Mesothelioma, Non Small Cell Lung Cancer, Malignant Peripheral Nerve Sheath Tumors Trial in United States (MRTX1719)

Recruiting
  • Mesothelioma
  • +5 more
  • Denver, Colorado
  • +5 more
Aug 8, 2022

Small Cell Lung Cancer, Uveal Melanoma, Ovarian Clear Cell Carcinoma Trial in United States (PLX2853)

Completed
  • Small Cell Lung Cancer
  • +7 more
  • Scottsdale, Arizona
  • +4 more
Jul 20, 2022

Solid Tumor Trial in United States (IDE397, Docetaxel, Paclitaxel)

Recruiting
  • Solid Tumor
  • Scottsdale, Arizona
  • +10 more
Jul 20, 2022

Solid Tumor Trial in United States (CI-8993)

Recruiting
  • Solid Tumor
  • Lebanon, New Hampshire
  • +4 more
Jul 19, 2022

Solid Tumor Trial in United States (KITE-718, Cyclophosphamide, Fludarabine)

Active, not recruiting
  • Solid Tumor
  • Gilbert, Arizona
  • +11 more
Apr 5, 2022

Solid Tumor Trial in Worldwide (Debio 1347)

Terminated
  • Solid Tumor
  • Debio 1347
  • Scottsdale, Arizona
  • +104 more
Mar 30, 2022

Lymphoma, B-Cell, Lymphoma, Non-Hodgkin, Leukemia, B-cell Trial in Worldwide (Ibrutinib)

Enrolling by invitation
  • Lymphoma, B-Cell
  • +4 more
  • Burbank, California
  • +90 more
Mar 31, 2022

Solid Tumor, CNS Tumor, Lymphoma Trial in Canada, United States (Neratinib)

Recruiting
  • Solid Tumor
  • +3 more
  • Phoenix, Arizona
  • +8 more
Mar 21, 2022

Cancer, Solid Tumor, Cancer of Skin Trial in New York (2141 V-11)

Recruiting
  • Cancer
  • +2 more
  • 2141 V-11
  • New York, New York
    Rockefeller University
Mar 15, 2022

Metastatic Cancer, Solid Tumor, Cholangiocarcinoma Trial in United States (LYT-200, Anti-PD-1, Gemcitabine/nab-paclitaxel)

Recruiting
  • Metastatic Cancer
  • +4 more
  • Phoenix, Arizona
  • +15 more
Mar 9, 2022

Head and Neck Squamous Cell Carcinoma, Breast Cancer, Sarcoma Trial in United States (Durvalumab, Tremelimumab, Poly ICLC)

Completed
  • Head and Neck Squamous Cell Carcinoma
  • +10 more
  • Atlanta, Georgia
  • +6 more
Mar 1, 2022

Solid Tumor Trial in United States (PF-07284892, lorlatinib, binimetinib)

Recruiting
  • Solid Tumor
  • Orange, California
  • +6 more
Feb 15, 2022

Solid Tumor, Clear Cell Renal Cell Carcinoma, TNBC - Triple-Negative Breast Cancer Trial in United States (CB-839, Talazoparib)

Terminated
Has Results
  • Solid Tumor
  • +6 more
  • Birmingham, Alabama
  • +8 more
Feb 16, 2022

Solid Tumor, Solid Tumor, Childhood, Solid Carcinoma Trial in United States (Romiplostim)

Recruiting
  • Solid Tumor
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
Feb 2, 2022

Solid Tumor, Lymphoma Trial in Worldwide (CX-072, ipilimumab, vemurafenib)

Completed
  • Solid Tumor
  • Lymphoma
  • Los Angeles, California
  • +30 more
Feb 7, 2022

Urothelial Carcinoma, Urothelial Carcinoma Bladder, Bladder Cancer Trial in United States (IK-175, IK-175 and nivolumab)

Recruiting
  • Urothelial Carcinoma
  • +20 more
  • Gilbert, Arizona
  • +9 more
Feb 3, 2022

Solid Tumor Trial in United States (OBT076, a CD205-directed antibody-drug conjugate)

Recruiting
  • Solid Tumor
  • OBT076, a CD205-directed antibody-drug conjugate
  • Los Angeles, California
  • +5 more
Jan 10, 2022

Solid Tumor Trial in United States (PLX3397)

Completed
Has Results
  • Solid Tumor
  • Scottsdale, Arizona
  • +12 more
Dec 6, 2021

Solid Tumor, Cancer, Recurrent Solid Tumors Trial in Germany, United States (IMA201 Product, IMADetect®)

Recruiting
  • Solid Tumor
  • +3 more
  • IMA201 Product
  • IMADetect®
  • Chicago, Illinois
  • +6 more
Dec 28, 2021